Protara Therapeutics Inc (TARA) Directors and Executive Officers - CSIMarket
CSIMarket
 
Protara Therapeutics Inc  (NASDAQ: TARA)

Protara Therapeutics Inc

Officers & Directors


PATRICK FABBIO
Chief Financial Officer

HANNAH FRY
Vice President, Controller

LUKE BESHAR
Chairman of the Board of Directors

JESSE SHEFFERMAN
President and Chief Executive Officer and Director

BARRY FLANNELLY, PHARM.D.
Director

ROGER GARCEAU, M.D.
Director

MICHAEL SOLOMON, PH.D.
Director

RICHARD LEVY, M.D.
Director

CYNTHIA SMITH
Director

GREGORY P. SARGEN
Director

JANE HUANG, M.D.
Director,

Protara Therapeutics Inc currently has 51 employees.

  News about Protara Therapeutics Inc Key Personnel

Protara Therapeutics Sees Stock Surge Following Positive Trial Results, Faces Financial Hurdles as It Aims for 2025 Milestones,

Protara Therapeutics Reports Promising Trial Results Amidst Financial ChallengesProtara Therapeutics Inc. a biopharmaceutical company focused on advancing therapies for rare diseases, has recently highlighted significant updates and anticipated milestones for 2025. Notably, the company reported positive six-month data from the ADVANCED-2 trial of TARA-002 in patients with non-muscle invasive bladder cancer (NMIBC). This announcement has bolstered investor confidence, pushing Protara’s stock price up an impressive 106.4% above its 52-week average on the NASDAQ.Despite this promising clinical progress, Protara also revealed a challenging financial landscape. During the 12 months ending in the third quarter o...

Protara Therapeutics Secures $45 Million in Private Placement Funding, Securing Cash Runway Extension up to 2026



Protara Therapeutics, a renowned innovative biopharmaceutical company, has recently announced the successful completion of an oversubscribed $45 million private placement financing round. The funding is expected to be instrumental in advancing the company s revolutionary drug development programs and extending its cash runway well into 2026. This significant achievement showcases the strong investor confidence in Protara s groundbreaking therapies and highlights the potential for robust growth and success in the coming years.
Recognizing the company s accomplishments and its unique position within the healthcare industry, Protara Therapeutics latest financing milestone exemplifies the resolve ...






TARA Management Effectiveness TARA Revenue per Employee TARA Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.